ADHD Awareness Month: A Time for Advocacy and Support
October is ADHD Awareness Month, an opportunity to shine a light on the experiences of individuals with Attention Deficit Hyperactivity Disorder and to raise awareness about the challenges they face. Launched in 2004 by a coalition of organisations including CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder), ADHD Awareness Month aims to educate the public, reduce stigma, and improve understanding of this often misunderstood condition.
ADHD is one of the most common neurodevelopmental disorders, affecting around 5% of children and 2.5% of adults worldwide. However, despite its prevalence, many individuals with ADHD go undiagnosed or face long waiting times for treatment within the NHS.
The NHS Waitlist Crisis:
In the UK, accessing a diagnosis and appropriate treatment for ADHD has become increasingly difficult, with the NHS facing a significant backlog. It’s reported that thousands of patients are on waiting lists that can stretch anywhere from six months to several years. This has led to many seeking private assessments or, in some cases, going untreated for prolonged periods, exacerbating symptoms and worsening quality of life. The strain on the NHS has left many individuals and families in limbo, awaiting the support they desperately need.
How Medical Cannabis Can Help ADHD Patients
In recent years, there has been growing interest in the use of medical cannabis as a treatment for ADHD. Studies report that cannabinoids help regulate dopamine levels in the brain, which are often imbalanced in individuals with ADHD. Many patients report improvements in focus, impulse control, and hyperactivity after using medical cannabis, providing a promising alternative for those who have not found relief through traditional medications.
Medical cannabis, particularly strains high in cannabidiol (CBD) and low in tetrahydrocannabinol (THC), can offer therapeutic benefits without the psychoactive effects commonly associated with cannabis use. For some, this can be a more tolerable option than stimulant medications like methylphenidate (Ritalin) or amphetamines, which can cause side effects such as insomnia, anxiety, and appetite suppression.
Advocacy and Awareness
As ADHD Awareness Month unfolds, it’s vital to advocate for better healthcare access, reduced stigma, and increased understanding of alternative treatments like medical cannabis. Raising awareness can help prompt policymakers to address the NHS waitlist crisis and encourage more research into the effectiveness of medical cannabis for ADHD.
How Mamedica Can Help
For those seeking support, Mamedica is committed to providing compassionate care and exploring the benefits of medical cannabis for ADHD patients.
If you would like to start your journey with Mamedica, you can check your eligibility here.